T1	Participants 70 94	moderate to severe COPD.
T2	Participants 368 420	in subjects with symptomatic moderate to severe COPD
T3	Participants 505 511	study.
T4	Participants 512 716	Subjects 40 years or older with cigarette smoking history ≥10 pack-years and with the diagnosis of COPD and post-bronchodilator FEV(1) ≥40 to ≤ 80% of predicted normal and FEV(1)/FVC of ≤0.70 were
T5	Participants 1593 1620	addition of FSC to subjects
